SCHEMBL27851968

SCHEMBL27851968

CC(C(=O)O)C(C)(N)c1cncc([N+](=O)[O-])c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
MAPT P10636 6/20 0.36
PTPRC P08575 1/20 0.35
CYP19A1 P11511 1/20 0.35
GAA P10253 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 1/20 0.33
HCAR3 P49019 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
GALR3 O60755 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27851984 0.80 PTPRC (0.55) ALDH1A1MAPTPTPRCSMN1; SMN2CYP2C19
SCHEMBL27868930 0.77 ALDH1A1 (0.39) ALDH1A1MAPTHTTKDM4ETDP1
SCHEMBL27851969 0.76 ALDH1A1 (0.36) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL17239860 0.74 SMN1; SMN2 (0.43) ALDH1A1MAPTPTPRCCYP19A1GAA
SCHEMBL287072 0.71 CYP2C19 (0.39) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL287071 0.71 CYP2C19 (0.39) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL12350175 0.69 ALDH1A1 (0.43) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL27851981 0.69 ALDH1A1 (0.43) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL31038446 0.68 ALDH1A1 (0.45) ALDH1A1MAPTCYP19A1TDP1RAB9A
SCHEMBL1507179 0.68 ALDH1A1 (0.45) ALDH1A1MAPTCYP19A1TDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102421760-A Dihydropyrimidinones useful as BACE2 inhibitors HOFFMANN LA ROCHE 2012-04-18 CN disclosed